Press release
Deadline on Sept. 13th coming up in Lawsuit for Investors in shares of Reckitt Benckiser Group plc (OTC: RBGLY)
A Deadline is coming up on September 13, 2019 in the lawsuit for certain investors in Reckitt Benckiser Group plc (OTC: RBGLY).
Investors who purchased shares of Reckitt Benckiser Group plc (OTC: RBGLY) have certain options and there are strict and short deadlines running. Deadline: September 13, 2019. OTC: RBGLY stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges on behalf of purchasers of Reckitt Benckiser Group plc (OTC: RBGLY), that Reckitt and its most senior executives perpetrated a scheme, which generated over $3 billion in proceeds, to facilitate opiate abuse among U.S. consumers and mislead investors and the public regarding the health and safety risks of Reckitt’s new key opiate product, Suboxone Film.
the complaint alleges that in order to maintain and grow profits, senior executives at Reckitt devised a plan to switch prescribers from Suboxone Tablets to the Company’s new proprietary treatment, Suboxone Film. Suboxone Film had similar active ingredients to Suboxone Tablets, however it was dispensed in a thin film placed under the tongue and stored in single-use foil wrappings. Executives planned to create a marketing campaign that touted the purported safety benefits of Suboxone Film over Suboxone Tablets in order to prevent generic competition. Key to this campaign was fabricating safety concerns with existing treatments in order to delay the entry and approval of generics for Suboxone Tablets. Defendants’ scheme to fraudulently inflate sales of Suboxone Film was a success. Between 2010 and 2014, the Company’s revenues from sales of the drug increased ten-fold to over $840 million annually.
Those who purchased shares of Reckitt Benckiser Group plc (OTC: RBGLY) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on Sept. 13th coming up in Lawsuit for Investors in shares of Reckitt Benckiser Group plc (OTC: RBGLY) here
News-ID: 1830702 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for Reckitt
Sigmoid enables significant cost reduction on Google Cloud Platform for Reckitt
Sigmoid, a leading data engineering and AI solutions firm, partnered with Reckitt a multinational consumer goods company, in successfully concluding a global cloud optimization initiative. This engagement helped Reckitt to improve their data infrastructure on the cloud and enable analytics solutions across marketing and supply chain.
With increasing data volumes and multiple business teams relying on access to high quality data, enhancing cloud performance was a strategic imperative for Reckitt. Unplanned…
Addiction Treatments Market | GlaxoSmithKline plc, Reckitt Benckiser plc, Pfizer …
Global Addiction Treatments Market: Snapshot
The menace of drugs has been dogging our society for decades on end now. On one hand, authorities and police are trying to curtail the problem with an iron hand, on the other hand, healthcare institutes and pharmaceutical companies are pulling out all stops to cure addiction.
Get Exclusive PDF Sample Copy Of This Report: https://www.tmrresearch.com/sample/sample?flag=B&rep_id=29
This has spawned the addiction treatments market which has expanded incrementally over…
Condom Market Growing Demand 2019 with top players Ansell Ltd (Richmond, Austral …
The Condom Market Report Highlights 2018 - 2026 of the market essentials, Industry review, opportunities, regional market, Emerging Growth Factors, characterization, application, innovation, industry chain investigation and most recent market progression and Competitors joined with their market share.
The Condom Market research report further delivers an meticulous outlook of the industry by studying key components impacting the industry such as Condom market growth, consumption volume, emerging trends and…
Wound Irrigation Solution Market : Reckitt Benckiser Group plc., Schulke & Mayr, …
Global Wound Irritation Systems Market: Overview
Wound irrigation refers to a procedure undertaken in the course of a variety of standard wound healing techniques that works by supplying a steady stream of a medicated solution to an open wound surface to assist with more reliable visual examination of the wound, to remove deeply located debris, and achieve wound hydration.
The goal of wound irrigation is chiefly to clean the wound while…
Interview released with Reckitt Benckiser, speaker at Pain Therapeutics 2019
SMi reports: An exclusive interview with Dalma Sugár, Global Medical Affairs Director, Reckitt Benckiser just ahead of SMi’s 19th Annual Pain Therapeutics Conference, taking place this May in London.
SMi Group are delighted to host the exclusive conference on Pain Therapeutics on the 13th and 14th May 2019 in London, which will bring in expert voices from those at the forefront of technological innovation and analgesic therapies. The 2019 agenda features…
Global Household Insecticides Market 2019 - Reckitt Benckiser, SC Johnson's, Ear …
Household insecticides include any substances applied to clothing, skin, or other surfaces to control or repel insects. Demand for insecticides is currently on the rise; ranging from sprays for controlling insect infestations in the kitchen, to weed killers for gardens and lawns and mosquito repellents for indoor or outdoor use. Household insecticides have been widely gaining acceptance to keep homes and gardens insect-free and to ensure safe and healthy living…
